Please login to the form below
13
Revenue 2017Bristol-Myers Squibb
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.
Amgen, Cytokinetics’ heart failure drug disappoints in phase 3
Earlier this week, Bristol Myers Squibb (BMS) announced that it was set to acquire cardiovascular specialist MyoKardia for $13.1bn.
BMS’ Opdivo is first immunotherapy to score phase 3 win in pre-surgery NSCLC
Bristol Myers Squibb (BMS) has reported a first-in-class win for its PD-1 inhibitor Opdivo after the immunotherapy demonstrated positive results in resectable, pre-surgery non-small cell lung
BMS picks up cardiovascular specialist MyoKardia for $13.1bn
Acquisition will bolster pipeline with targeted cardiovascular therapies. Bristol Myers Squibb (BMS) is set to acquire MyoKardia for $13.1bn, in an effort to bolster its pipeline with targeted cardiovascular therapies. ... chief executive officer of
Switzerland: a life sciences hub
Celgene, now a subsidiary of Bristol-Myers Squibb (BMS), recently built its second production plant in Couvet, followed by the construction of a third production site in Boudry (Neuchâtel), to produce
FDA hands BMS and bluebird bio a priority review for ide-cel
Myer Squibb and bluebird bio’s submission for their CAR-T immunotherapy ide-cel has finally been accepted by the agency. ... Together with our partners at Bristol Myers Squibb, we are committed to continue working with the FDA to deliver this promising
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
- Send Us a Message
PMHub
Spirit
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...
Latest intelligence
- Article
- How will COVID-19 affect uptake of vaccinations against other diseases?...
- Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
- Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
- Podcast
- Living With Chronic Illness (Series one)...
Quick links
Infographics
